← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $51K of Replimune Group, Inc.

Sold$51,167
$14.59Price
3,507Shares
−2%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Mon, May 16. Filed Wed, May 18, 3:03 PM ET, during the session. Not investment advice.